• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于文库筛选的策略,用于鉴定DARPins作为靶向受体的腺相关病毒和慢病毒载体的配体。

A Library-Based Screening Strategy for the Identification of DARPins as Ligands for Receptor-Targeted AAV and Lentiviral Vectors.

作者信息

Hartmann Jessica, Münch Robert C, Freiling Ruth-Therese, Schneider Irene C, Dreier Birgit, Samukange Washington, Koch Joachim, Seeger Markus A, Plückthun Andreas, Buchholz Christian J

机构信息

Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.

Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.

出版信息

Mol Ther Methods Clin Dev. 2018 Jul 6;10:128-143. doi: 10.1016/j.omtm.2018.07.001. eCollection 2018 Sep 21.

DOI:10.1016/j.omtm.2018.07.001
PMID:30101151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6077149/
Abstract

Delivering genes selectively to the therapeutically relevant cell type is among the prime goals of vector development. Here, we present a high-throughput selection and screening process that identifies designed ankyrin repeat proteins (DARPins) optimally suited for receptor-targeted gene delivery using adeno-associated viral (AAV) and lentiviral (LV) vectors. In particular, the process includes expression, purification, and biotinylation of the extracellular domains of target receptors as Fc fusion proteins in mammalian cells and the selection of high-affinity binders by ribosome display from DARPin libraries each covering more than 10 variants. This way, DARPins specific for the glutamate receptor subunit GluA4, the endothelial surface marker CD105, and the natural killer cell marker NKp46 were generated. The identification of DARPins best suited for gene delivery was achieved by screening small-scale vector productions. Both LV and AAV particles displaying the selected DARPins transduced only cells expressing the corresponding target receptor. The data confirm that a straightforward process for the generation of receptor-targeted viral vectors has been established. Moreover, biochemical analysis of a panel of DARPins revealed that their functional cell-surface expression as fusion proteins is more relevant for efficient gene delivery by LV particles than functional binding affinity.

摘要

将基因选择性地递送至具有治疗相关性的细胞类型是载体开发的主要目标之一。在此,我们展示了一种高通量筛选过程,该过程可鉴定出最适合使用腺相关病毒(AAV)和慢病毒(LV)载体进行受体靶向基因递送的设计锚蛋白重复序列蛋白(DARPins)。具体而言,该过程包括在哺乳动物细胞中表达、纯化并生物素化作为Fc融合蛋白的靶受体胞外结构域,以及通过核糖体展示从每个覆盖超过10种变体的DARPin文库中筛选高亲和力结合物。通过这种方式,生成了对谷氨酸受体亚基GluA4、内皮表面标志物CD105和自然杀伤细胞标志物NKp46具有特异性的DARPins。通过筛选小规模载体生产实现了对最适合基因递送的DARPins的鉴定。展示所选DARPins的LV和AAV颗粒仅转导表达相应靶受体的细胞。数据证实已建立了一种生成受体靶向病毒载体的直接方法。此外,对一组DARPins的生化分析表明,它们作为融合蛋白在功能上的细胞表面表达对于LV颗粒有效基因递送比功能结合亲和力更重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/32b7a8bdb5b7/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/a9fc0e7c3284/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/ebd14dee4b74/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/65ab243c17ab/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/e4914d22f943/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/c60d8575f98c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/47e974bcf2e0/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/785f5e3a12d8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/32b7a8bdb5b7/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/a9fc0e7c3284/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/ebd14dee4b74/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/65ab243c17ab/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/e4914d22f943/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/c60d8575f98c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/47e974bcf2e0/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/785f5e3a12d8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9682/6077149/32b7a8bdb5b7/gr8.jpg

相似文献

1
A Library-Based Screening Strategy for the Identification of DARPins as Ligands for Receptor-Targeted AAV and Lentiviral Vectors.一种基于文库筛选的策略,用于鉴定DARPins作为靶向受体的腺相关病毒和慢病毒载体的配体。
Mol Ther Methods Clin Dev. 2018 Jul 6;10:128-143. doi: 10.1016/j.omtm.2018.07.001. eCollection 2018 Sep 21.
2
GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry.靶向GluA4的腺相关病毒载体在依赖腺相关病毒受体进入细胞的同时,能将基因选择性地传递给中间神经元。
Mol Ther Methods Clin Dev. 2019 Jul 23;14:252-260. doi: 10.1016/j.omtm.2019.07.004. eCollection 2019 Sep 13.
3
Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8.当靶向小鼠CD8时,慢病毒载体和腺相关病毒载体可有效地转导小鼠T淋巴细胞。
Mol Ther Methods Clin Dev. 2021 Oct 1;23:334-347. doi: 10.1016/j.omtm.2021.09.014. eCollection 2021 Dec 10.
4
AAV vectors displaying bispecific DARPins enable dual-control targeted gene delivery.AAV 载体展示双特异性 DARPins 可实现双控制靶向基因传递。
Biomaterials. 2023 Dec;303:122399. doi: 10.1016/j.biomaterials.2023.122399. Epub 2023 Nov 16.
5
Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transfer.通过蛋白转译拼接将高亲和性配体共价偶联到病毒载体颗粒的表面介导了特定细胞类型的基因转移。
Biomaterials. 2017 Nov;144:84-94. doi: 10.1016/j.biomaterials.2017.07.032. Epub 2017 Jul 25.
6
CD8-Specific Designed Ankyrin Repeat Proteins Improve Selective Gene Delivery into Human and Primate T Lymphocytes.CD8特异性设计的锚蛋白重复序列蛋白可改善对人及灵长类T淋巴细胞的选择性基因递送。
Hum Gene Ther. 2020 Jun;31(11-12):679-691. doi: 10.1089/hum.2019.248. Epub 2020 Apr 23.
7
Substantially improved gene transfer to interneurons with second-generation glutamate receptor-targeted DART-AAV vectors.第二代谷氨酸受体靶向 DART-AAV 载体可显著提高中间神经元的基因转移效率。
J Neurosci Methods. 2023 Nov 1;399:109981. doi: 10.1016/j.jneumeth.2023.109981. Epub 2023 Sep 30.
8
DARPins: an efficient targeting domain for lentiviral vectors.DARPins:慢病毒载体的高效靶向结构域。
Mol Ther. 2011 Apr;19(4):686-93. doi: 10.1038/mt.2010.298. Epub 2011 Jan 11.
9
DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency.通过噬菌体展示和核糖体展示选择的、针对肿瘤相关抗原 EpCAM 的 DARPins,并进行多价工程改造。
J Mol Biol. 2011 Nov 4;413(4):826-43. doi: 10.1016/j.jmb.2011.09.016. Epub 2011 Sep 21.
10
Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display.使用信号识别颗粒(SRP)噬菌体展示技术高效筛选具有亚纳摩尔亲和力的设计锚蛋白重复域(DARPin)。
J Mol Biol. 2008 Oct 24;382(5):1211-27. doi: 10.1016/j.jmb.2008.07.085. Epub 2008 Aug 6.

引用本文的文献

1
Identification of AAV variants with improved transduction of human vascular endothelial cells by screening AAV capsid libraries in non-human primates.通过在非人类灵长类动物中筛选腺相关病毒(AAV)衣壳文库来鉴定对人血管内皮细胞转导能力有所改善的AAV变体。
Gene Ther. 2025 Aug 22. doi: 10.1038/s41434-025-00563-4.
2
Chemical approaches to probe and engineer AAV vectors.化学方法探究和工程化 AAV 载体。
Nanoscale. 2024 Jul 25;16(29):13820-13833. doi: 10.1039/d4nr01300j.
3
Improving the pharmacokinetics, biodistribution and plasma stability of monobodies.

本文引用的文献

1
Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control.带有屏蔽和适配子的腺病毒载体增加了肿瘤的特异性,并逃避了肝脏和免疫的控制。
Nat Commun. 2018 Jan 31;9(1):450. doi: 10.1038/s41467-017-02707-6.
2
First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient.首例人类应用靶向树突状细胞的慢病毒载体表达 NY-ESO-1、LV305 治疗难治性转移性滑膜肉瘤患者,诱导深度、持久应答。
J Immunother. 2017 Oct;40(8):302-306. doi: 10.1097/CJI.0000000000000183.
3
Virotherapy Research in Germany: From Engineering to Translation.
改善单域抗体的药代动力学、生物分布和血浆稳定性。
Front Pharmacol. 2024 Apr 4;15. doi: 10.3389/fphar.2024.1393112.
4
Designed Ankyrin Repeat Proteins as Actin Labels of Distinct Cytoskeletal Structures in Living Cells.设计锚蛋白重复蛋白作为活细胞中不同细胞骨架结构的肌动蛋白标记物。
ACS Nano. 2024 Mar 26;18(12):8919-8933. doi: 10.1021/acsnano.3c12265. Epub 2024 Mar 15.
5
rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing.重组腺相关病毒(rAAV)生产:上游加工过程中的软传感挑战
Bioengineering (Basel). 2023 Feb 8;10(2):229. doi: 10.3390/bioengineering10020229.
6
Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.设计锚蛋白重复蛋白:一类新型病毒进入抑制剂。
Viruses. 2022 Oct 12;14(10):2242. doi: 10.3390/v14102242.
7
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions.癌症免疫治疗中胞内抗体的治疗潜力:现状与未来方向
Antibodies (Basel). 2022 Jul 18;11(3):49. doi: 10.3390/antib11030049.
8
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice.在体工程化 B 细胞在小鼠体内分泌高滴度的广谱中和抗 HIV 抗体。
Nat Biotechnol. 2022 Aug;40(8):1241-1249. doi: 10.1038/s41587-022-01328-9. Epub 2022 Jun 9.
9
Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms.精准医疗:体内 CAR 疗法作为受体靶向载体平台的范例。
Mol Ther. 2022 Jul 6;30(7):2401-2415. doi: 10.1016/j.ymthe.2022.05.018. Epub 2022 May 20.
10
Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8.当靶向小鼠CD8时,慢病毒载体和腺相关病毒载体可有效地转导小鼠T淋巴细胞。
Mol Ther Methods Clin Dev. 2021 Oct 1;23:334-347. doi: 10.1016/j.omtm.2021.09.014. eCollection 2021 Dec 10.
德国病毒疗法研究:从工程到转化。
Hum Gene Ther. 2017 Oct;28(10):800-819. doi: 10.1089/hum.2017.138.
4
Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.小而强大:AAV 载体研究、设计和进化的最新进展。
Hum Gene Ther. 2017 Nov;28(11):1075-1086. doi: 10.1089/hum.2017.172. Epub 2017 Aug 23.
5
Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transfer.通过蛋白转译拼接将高亲和性配体共价偶联到病毒载体颗粒的表面介导了特定细胞类型的基因转移。
Biomaterials. 2017 Nov;144:84-94. doi: 10.1016/j.biomaterials.2017.07.032. Epub 2017 Jul 25.
6
Gene therapy and editing: Novel potential treatments for neuronal channelopathies.基因治疗与编辑:治疗神经元通道病的新潜在疗法。
Neuropharmacology. 2018 Apr;132:108-117. doi: 10.1016/j.neuropharm.2017.05.029. Epub 2017 May 28.
7
Targeting natural killer cells in cancer immunotherapy.在癌症免疫疗法中靶向自然杀伤细胞。
Nat Immunol. 2016 Aug 19;17(9):1025-36. doi: 10.1038/ni.3518.
8
Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment.受体靶向尼帕病毒糖蛋白改善细胞类型选择性基因递送并揭示对膜近端细胞附着的偏好。
PLoS Pathog. 2016 Jun 9;12(6):e1005641. doi: 10.1371/journal.ppat.1005641. eCollection 2016 Jun.
9
Clinical development of gene therapy: results and lessons from recent successes.基因治疗的临床发展:近期成功的结果和经验教训。
Mol Ther Methods Clin Dev. 2016 May 25;3:16034. doi: 10.1038/mtm.2016.34. eCollection 2016.
10
An essential receptor for adeno-associated virus infection.腺相关病毒感染的一种必需受体。
Nature. 2016 Feb 4;530(7588):108-12. doi: 10.1038/nature16465. Epub 2016 Jan 27.